Dianthus Therapeutics, Inc. /DE/

T. Rowe Price Investment Management, Inc. DNTH

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/14/2026

Shares

3,888,456

Value ($000)

379,047

Weight

0.2%

2026 Q1 - 2026 Q2 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/14/2026	379,047	0.2%	3,888,456	6/30/2026
2026 Q1	5/15/2026	108,440	0.1%	1,292,182	3/31/2026